Omega Fund Vi Gp Manager, Ltd. - Net Worth and Insider Trading

Omega Fund Vi Gp Manager, Ltd. Net Worth

The estimated net worth of Omega Fund Vi Gp Manager, Ltd. is at least $4 Million dollars as of 2024-04-27. Omega Fund Vi Gp Manager, Ltd. is the of Theseus Pharmaceuticals Inc and owns about 711,479 shares of Theseus Pharmaceuticals Inc (THRX) stock worth over $3 Million. Omega Fund Vi Gp Manager, Ltd. is also the 10% Owner of Spruce Biosciences Inc and owns about 2,161,022 shares of Spruce Biosciences Inc (SPRB) stock worth over $2 Million. Details can be seen in Omega Fund Vi Gp Manager, Ltd.'s Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Omega Fund Vi Gp Manager, Ltd. has not made any transactions after 2021-10-12 and currently still holds the listed stock(s).

Transaction Summary of Omega Fund Vi Gp Manager, Ltd.

To

Omega Fund Vi Gp Manager, Ltd. Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Omega Fund Vi Gp Manager, Ltd. owns 5 companies in total, including Spruce Biosciences Inc (SPRB) , Imago BioSciences Inc (IMGO) , and Theseus Pharmaceuticals Inc (THRX) among others .

Click here to see the complete history of Omega Fund Vi Gp Manager, Ltd.’s form 4 insider trades.

Insider Ownership Summary of Omega Fund Vi Gp Manager, Ltd.

Ticker Comapny Transaction Date Type of Owner
SPRB Spruce Biosciences Inc 2020-10-14 10 percent owner
IMGO Imago BioSciences Inc 2021-07-15 10 percent owner
THRX Theseus Pharmaceuticals Inc 2021-10-12 10 percent owner
OMEG Omega Alpha SPAC 2021-01-06 10 percent owner
LXEO Lexeo Therapeutics Inc 2023-11-02 10 percent owner

Omega Fund Vi Gp Manager, Ltd. Latest Holdings Summary

Omega Fund Vi Gp Manager, Ltd. currently owns a total of 2 stocks. Among these stocks, Omega Fund Vi Gp Manager, Ltd. owns 711,479 shares of Theseus Pharmaceuticals Inc (THRX) as of October 12, 2021, with a value of $3 Million and a weighting of 65.63%. Omega Fund Vi Gp Manager, Ltd. also owns 2,161,022 shares of Spruce Biosciences Inc (SPRB) as of October 14, 2020, with a value of $2 Million and a weighting of 34.37%.

Latest Holdings of Omega Fund Vi Gp Manager, Ltd.

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
THRX Theseus Pharmaceuticals Inc 2021-10-12 711,479 4.06 2,888,605
SPRB Spruce Biosciences Inc 2020-10-14 2,161,022 0.70 1,512,715

Holding Weightings of Omega Fund Vi Gp Manager, Ltd.


Omega Fund Vi Gp Manager, Ltd. Form 4 Trading Tracker

According to the SEC Form 4 filings, Omega Fund Vi Gp Manager, Ltd. has made a total of 1 transactions in Theseus Pharmaceuticals Inc (THRX) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in Theseus Pharmaceuticals Inc is the acquisition of 187,500 shares on October 12, 2021, which cost Omega Fund Vi Gp Manager, Ltd. around $3 Million.

According to the SEC Form 4 filings, Omega Fund Vi Gp Manager, Ltd. has made a total of 1 transactions in Spruce Biosciences Inc (SPRB) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in Spruce Biosciences Inc is the acquisition of 250,000 shares on October 14, 2020, which cost Omega Fund Vi Gp Manager, Ltd. around $4 Million.

Insider Trading History of Omega Fund Vi Gp Manager, Ltd.

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Omega Fund Vi Gp Manager, Ltd. Trading Performance

GuruFocus tracks the stock performance after each of Omega Fund Vi Gp Manager, Ltd.'s buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Omega Fund Vi Gp Manager, Ltd. is -1.19%. GuruFocus also compares Omega Fund Vi Gp Manager, Ltd.'s trading performance to market benchmark return within the same time period. The performance of stocks bought by Omega Fund Vi Gp Manager, Ltd. within 3 months outperforms 1 times out of 2 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how Omega Fund Vi Gp Manager, Ltd.'s insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of Omega Fund Vi Gp Manager, Ltd.

Average Return

-68.24%

Average return per transaction

Outperforming Transactions

0%

0 out of 2 outperforming transactions.
Each transaction is measured over a period and compared to .
1 Month 3 Months 6 Months 1 Year 2 Years 3 Years
Return(%) 19.65 -1.19 -13.55 -68.24 -67.9 -55.37
Relative Return to S&P 500(%) 14.45 -9.91 -23.2 -72.96 -68.56 -62.83

Omega Fund Vi Gp Manager, Ltd. Ownership Network

Ownership Network List of Omega Fund Vi Gp Manager, Ltd.

No Data

Ownership Network Relation of Omega Fund Vi Gp Manager, Ltd.


Omega Fund Vi Gp Manager, Ltd. Owned Company Details

What does Spruce Biosciences Inc do?

Who are the key executives at Spruce Biosciences Inc?

Omega Fund Vi Gp Manager, Ltd. is the 10 percent owner of Spruce Biosciences Inc. Other key executives at Spruce Biosciences Inc include 10 percent owner Novo Holdings A/s , Chief Medical Officer Charlton Ralph William Iii , and director & Chief Executive Officer Javier B. Szwarcberg .

Spruce Biosciences Inc (SPRB) Insider Trades Summary

Over the past 18 months, Omega Fund Vi Gp Manager, Ltd. made no insider transaction in Spruce Biosciences Inc (SPRB). Other recent insider transactions involving Spruce Biosciences Inc (SPRB) include a net sale of 1,964,336 shares made by Novo Holdings A/s , and a net purchase of 630,400 shares made by Niall O'donnell .

In summary, during the past 3 months, insiders sold 4,172,336 shares of Spruce Biosciences Inc (SPRB) in total and bought 0 shares, with a net sale of 4,172,336 shares. During the past 18 months, 4,172,336 shares of Spruce Biosciences Inc (SPRB) were sold and 2,838,400 shares were bought by its insiders, resulting in a net sale of 1,333,936 shares.

Spruce Biosciences Inc (SPRB)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Spruce Biosciences Inc Insider Transactions

No Available Data

Omega Fund Vi Gp Manager, Ltd. Mailing Address

Above is the net worth, insider trading, and ownership report for Omega Fund Vi Gp Manager, Ltd.. You might contact Omega Fund Vi Gp Manager, Ltd. via mailing address: 888 Boylston Street, Suite 1111, Boston Ma 02199.

Discussions on Omega Fund Vi Gp Manager, Ltd.

No discussions yet.